What is WO2003077914A1, and how is it related to binimetinib?
WO2003077914A1 is a published patent application identified by the WIPO publication number “WO 2003/077914 A1”. To link it specifically to binimetinib, you would check the patent’s claims and description for any mention of:
- “binimetinib” (or synonyms/codenames)
- chemical structures, IUPAC names, or formulae matching binimetinib
- compounds described as MEK inhibitors (binimetinib is a MEK inhibitor)
With only the information provided (the publication number and the drug name), I can’t confirm from the record itself whether WO2003077914A1 is directly about binimetinib or just about related MEK inhibition chemistry. You can verify quickly by searching within the patent text for “binimetinib”, “MEK”, and the compound’s structural identifiers.
How to find the binimetinib passages inside Google Patents for WO2003077914A1
On Google Patents, open WO2003077914A1 and use the page search to locate:
- “binimetinib”
- “MEK” / “mitogen-activated protein kinase kinase”
- terms like “Example”, “Compound”, “Formula”, “Claim”
- any lists of “embodiments” or “preferred compounds” that include the specific structure
If binimetinib is not explicitly named, look for the compound described by a chemical structure or formula in the examples and compare it to binimetinib’s known structure/chemical name.
What if WO2003077914A1 mentions MEK inhibitors but not binimetinib by name?
That can happen if a patent covers a broader class of compounds (e.g., MEK inhibitors) where binimetinib is one member, but the application uses a generic class description rather than the eventual commercial name. In that case:
- the key evidence is the specific compound entries (examples/embodiments) and the claim scope
- the “relevance” to binimetinib is stronger if a claim explicitly covers the compound or its close structural equivalents
Can this help with “who owns binimetinib” or patent coverage questions?
Yes, but only if WO2003077914A1 is actually part of the binimetinib patent family. To determine that, you would compare:
- assignee/applicant names in the publication
- the filing/priority dates
- whether other publications in the same family name binimetinib or include its structure in claims/examples
This is commonly how people map out patent families for drug molecules.
What I need from you to answer precisely (instead of generally)
If you paste either:
1) the Google Patents page URL for WO2003077914A1, or
2) the “Title”, “Abstract”, and one or two of the first claims (or the relevant compound/example section text),
…I can tell you whether the document is directly about binimetinib, which claims/sections relate to it, and how strong that connection is.
Sources
None were provided in your message.